Company: IPST
Filing Date: 2025-10-16
Form Type: S-1/A
Source: 0001213900-25-099309
Chunk: 341

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-10-16
Form: S-1/A
Chunk 341
---
 issued in connection with the issuance of Series B Preferred Stock (of which, and were to a related party); and Whiskey Note Shareholder Warrants to purchase common stock at $ per share; and, and Commitment Warrants to purchase common stock at $ per share issued in connection with the ELOC Agreement (that were exercised in February, 2025).

In addition to the Contingent Legacy Shareholder Warrants discussed above, during the year ended December 31, 2024, the Company issued a total of equity classified warrants, including: warrants at $ per share in conjunction with July 2024 accounts receivable factoring agreement; Underwriter Warrants in conjunction with the Company’s initial public offering; and, warrants to purchase common stock, (of which, were to a related party) in connection with the issuance of Series A Preferred Stock. Upon the November 25, 2024 initial public offering at $ per share, the warrants at $ per share were recalculated and reissued as warrants at $ per share (and the related party warrants at $ per share were recalculated and reissued as warrants at $ per share.).

|                                           |     |       For the 
    Six Months 
         Ended 
 June 30, 2025 |     |      For the 
   Year Ended 
 December 31, 
         2024 |
|:------------------------------------------|:----|--------------:|:----|-------------:|
| Weighted Average Expected Volatility      |     |           70% |     |          70% |
| Expected Dividends                        |     |            —% |     |           —% |
| Weighted Average Expected Term (in years) |     |             5 |     |            5 |
| Risk-Free Interest Rate                   |     | 3.88% – 4.66% |     |        4.22% |

As of June 30, 2025 and December 31, 2024, in addition to the Contingent Legacy Shareholder Warrants discussed above, there were outstanding and exercisable warrants to purchase and , respectively, shares of common stock, As of June 30, 2025, the weighted-average remaining contractual term was years for the outstanding and exercisable warrants.

The Underwriting Agreement and the related warrants granted to the Underwriter equal % of the total proceeds raised in the Company’s November 25, 2024 initial public offering at an exercise price equal to the offering price, or warrants for